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Dear Editor,
we read with great interest the paper by Dr. Chen et al1, recently published in European 
Review for Medical and Pharmacological Sciences and titled ‘‘Promotion of proliferation and 
metastasis of hepatocellular carcinoma by LncRNA00673 based on the targeted-regulation 
of notch signaling pathway’’. Authors concluded that lncRNA00673 is highly expressed and 
may be a potential target for the treatment of Hepatocellular Carcinoma (HCC). Moreover, 
according to authors, it can promote the proliferation and metastasis of HCC by the regulation 
of Notch signaling pathway. We congratulate the authors for their interesting work. 
The role of lncRNAs in oncogenesis is currently of great interest and several studies 
focused on their implications2. In the last years, increasing evidence showed that non-coding 
RNAs represent functional molecules participating in different physiological and pathological 
processes. In addition to small non-coding RNAs (small nuclear RNAs, small nucleolar RNAs, 
microRNAs, piwi-interacting RNAs, small interfering RNAs) that were well characterized for 
their function, more recently long non-coding RNAs (lncRNAs) have been explored to analyze 
their roles. lncRNAs show a lot of similarities with mRNAs, even if generally expressed at a 
lower level, and can localize in specific compartments of the cell. Based on their localization, 
they can exert different biological functions3. Nuclear lncRNAs are mainly involved in the 
recruitment of transcriptional factors or chromatin modifiers (both DNA and histone modifying 
enzymes), thanks to their ability to be structured in functional domains able to interact 
with proteins2,4,5. Cytoplasmic lncRNAs exert other functions at post-transcriptional levels by 
controlling the stability of messenger RNAs or by sequestering miRNAs acting as competing 
for endogenous RNAs (ceRNAs). miRNAs and lncRNAs are often dysregulated in pathological 
conditions. Notably, respect to liver cancer, it has been reported that non-coding RNAs play 
a primary role in hepatocarcinogenic processes5-7. Well-described examples for functionally 
important lncRNAs are HOTAIR, HULC, TERC, HOXA-AS2, CASC2, HOXD-AS1, PVT1, SPRY4-IT1, 
MALAT1, DREH, CCAT2.
This evidence suggests that a better understanding of how lncRNAs exert their functions 
in hepato-carcinogenesis could be useful in finding some solutions for liver cancer treatment. 
After the detection of lncRNAs expression (especially in the earlier phases of the disease), some 
strategies of lncRNAs-based treatment should be taken into account. The control of lncRNAs 
levels could open the way to a more target-specific therapy counteracting the epigenetic 
modifications guided by lncRNAs recruiting chromatin-remodeling complexes at specific loci. 
As a result, cells could re-acquire their polarity, the epithelial phenotype, the adhesion to the 
other cells, while losing invasive and migratory properties.
Recently, Chen et al1 reported that lncRNA00673, a 2275bp long non-coding RNA, plays a 
role in tumour biology. In non-small-cell lung cancer cells, it is expressed at high levels and is 
able to interact with both LSD1 on the promoter of NCALD, thus, promoting cell proliferation, 
and PRC2 on the regulatory regions of HOXA5. Specifically, they show that lncRNA00673 is 
expressed at high levels in liver tumour samples and in HCC cell lines compared to control. 
More interestingly, the depletion of lncRNA00673 through an RNA interference approach on 
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HCC cell lines displays that this non-coding RNA is involved in the maintenance of tumour cells 
proliferation since cells transfected with siRNAs were retarded in G0-G1 phase. Additionally, 
lncRNA00673 depletion induces an increase in the apoptotic rate while diminishing the 
metastatic and invasive capacities and the expression of Notch pathway genes. 
This work confirms that lncRNAs play a central role in tumor cell proliferation, apoptosis, 
epithelial to mesenchymal transition (EMT) by regulating different pathways, such as Notch 
pathway in the case of lncRNA00673. The understanding of the molecular players and processes 
involved in HCC onset and development could represent the starting point to prevent a liver 
tumor, by identifying molecular markers, and to develop new therapies for HCC treatment. 
In summary, since currently adopted staging systems do not include any tumor-specific 
biological prognostic factors, further studies on intracellular pathways and tumor-stroma 
cross-talk are needed to improve diagnosis and management of HCC8-12.
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